Resveratrol and pharmacological potentiation in ischemic stroke

Neurosurgery

Volumn 74, Issue 6, 2014, Pages

  Weiner, Gregory M ^a   Ducruet, Andrew F ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RESVERATROL; THIOCTIC ACID; STILBENE DERIVATIVE;

ANTIOXIDANT ACTIVITY; BRAIN ISCHEMIA; DRUG POTENTIATION; HUMAN; LASER DOPPLER FLOWMETRY; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; NOTE; PRIORITY JOURNAL; ANIMAL; DISEASE MODEL; STROKE; TREATMENT OUTCOME;

ANIMALS; BRAIN ISCHEMIA; DISEASE MODELS, ANIMAL; HUMANS; STILBENES; STROKE; TREATMENT OUTCOME;

EID: 84901400890     PISSN: 0148396X     EISSN: 15244040     Source Type: Journal    
DOI: 10.1227/01.neu.0000450234.14363.07     Document Type: Note

References (4)

1. Raval AP, Dave KR, Pérez-Pinzón MA. Resveratrol mimics ischemic preconditioning in the brain. J Cereb Blood Flow Metab. 2006;26(9):1141-1147 (Pubitemid 44268176)
2. Della-Morte D, Dave KR, DeFazio RA, Bao YC, Raval AP, Perez-Pinzon MA. Resveratrol pretreatment protects rat brain from cerebral ischemic damage via a sirtuin 1-uncoupling protein 2 pathway. Neuroscience. 2009;159(3):993-1002.
3. Saleh MC, Connell BJ, Rajagopal D, et al. Co-administration of resveratrol and lipoic acid, or their synthetic combination, enhances neuroprotection in a rat model of ischemia/reperfusion. PLoS One. 2014;9(1):e87865
4. Qin C, Tan KL, Zhang CL, Tan CY, Chen YZ, Jiang YY. What does it take to synergistically combine sub-potent natural products into drug-level potent combinations? PLoS One. 2012;7(11):e49969